S100A4 and cancer: Taken together, the identification of S100A4-mediated transcriptome revealed the transcriptional cross-regulation of the metastasis-inducing S100A4 and the Wnt antagonist DKK1, dominated by S100A4, which leads to increased cell motility, cancer progression and metastasis, and decreased survival of CRC patients.